Ibrutinib combined with bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): First results from a randomized, double-blind, placebo-controlled, phase III study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chanan-Khan, Asher Alban Akmal
  • Cramer, Paula
  • Demirkan, Fatih
  • Fraser, Graeme
  • Silva, Rodrigo Santucci
  • Pylypenko, Halyna
  • Grosicki, Sebastian
  • Janssens, Ann
  • Pristupa, Alexander
  • Mayer, Jiri
  • Dilhuydy, Marie-Sarah
  • Loscertales, Javier
  • Bartlett, Nancy L
  • Avigdor, Abraham
  • Rule, Simon
  • Sun, Steven
  • Mahler, Michelle
  • Salman, Mariya
  • Howes, Angela J
  • Hallek, Michael J

publication date

  • June 20, 2015